Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Ayton

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
JAMA Neurology|November 4, 2024
Deferiprone in Alzheimer Disease: A Randomized Clinical TrialScott Ayton, David Barton, Bruce Brew, et al.
Signal Transduction and Targeted Therapy|February 24, 2022
Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusionQing-Zhang Tuo, Yu Liu, Zheng Xiang, et al.
Cell Metabolism|February 5, 2022
Selenium mediates exercise-induced adult neurogenesis and reverses learning deficits induced by hippocampal injury and agingOdette Leiter, Zhan Zhuo, Ruslan Rust, et al.
Acta Neuropathologica Communications|September 30, 2021
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Acta Neuropathologica Communications|June 30, 2017
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
The Journal of Experimental Medicine|April 5, 2012
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's diseaseLin W Hung, Victor L Villemagne, Lesley Cheng, et al.
The New England Journal of Medicine|November 30, 2022
Trial of Deferiprone in Parkinson's DiseaseDavid Devos, Julien Labreuche, Olivier Rascol, et al.
Autophagy|March 5, 2024
International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosisXin Chen, Andrey S Tsvetkov, Han-Ming Shen, et al.
Cell|December 5, 2025
A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosisSvenja M Lorenz, Adam Wahida, Mark J Bostock, et al.
Redox Biology|June 22, 2024
Ferroptosis in health and diseaseCarsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
JAMA Neurology|November 4, 2024
Deferiprone in Alzheimer Disease: A Randomized Clinical TrialScott Ayton, David Barton, Bruce Brew, et al.
Signal Transduction and Targeted Therapy|February 24, 2022
Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusionQing-Zhang Tuo, Yu Liu, Zheng Xiang, et al.
Cell Metabolism|February 5, 2022
Selenium mediates exercise-induced adult neurogenesis and reverses learning deficits induced by hippocampal injury and agingOdette Leiter, Zhan Zhuo, Ruslan Rust, et al.
Acta Neuropathologica Communications|September 30, 2021
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Acta Neuropathologica Communications|June 30, 2017
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
The Journal of Experimental Medicine|April 5, 2012
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's diseaseLin W Hung, Victor L Villemagne, Lesley Cheng, et al.
The New England Journal of Medicine|November 30, 2022
Trial of Deferiprone in Parkinson's DiseaseDavid Devos, Julien Labreuche, Olivier Rascol, et al.
Autophagy|March 5, 2024
International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosisXin Chen, Andrey S Tsvetkov, Han-Ming Shen, et al.
Cell|December 5, 2025
A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosisSvenja M Lorenz, Adam Wahida, Mark J Bostock, et al.
Redox Biology|June 22, 2024
Ferroptosis in health and diseaseCarsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Pageof 15